David Pace, Ameneh Khatami, Jennifer McKenna, Danielle Campbell, Simon Attard-Montalto, Jacqueline Birks, Merryn Voysey, Catherine White, Adam Finn, Emma Macloed, Saul N Faust, Alison Louise Kent, Paul T Heath, Ray Borrow, Matthew D Snape, Andrew J Pollard
OBJECTIVE: To determine whether the immunogenicity of a single dose infant priming schedule of serogroup C meningococcal (MenC) conjugate vaccine is non-inferior to a two dose priming schedule when followed by a booster dose at age 12 months. DESIGN: Phase IV open label randomised controlled trial carried out from July 2010 until August 2013 SETTING: Four centres in the United Kingdom and one centre in Malta. PARTICIPANTS: Healthy infants aged 6-12 weeks followed up until age 24 months...
April 1, 2015: BMJ: British Medical Journal